story of the week
Statin Use Reduces Hepatocellular Carcinoma Risk in Patients With NAFLD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Gastroenterology and Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Statin Use and Reduced Hepatocellular Carcinoma Risk in Patients With Nonalcoholic Fatty Liver Disease
Clin. Gastroenterol. Hepatol. 2023 Feb 01;21(2)435-444.e6, B Zou, MC Odden, MH NguyenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.